APERIO CLINICAL OUTCOMES Trademark

Trademark Overview


On Monday, May 20, 2019, a trademark application was filed for APERIO CLINICAL OUTCOMES with the United States Patent and Trademark Office. The USPTO has given the APERIO CLINICAL OUTCOMES trademark a serial number of 88438039. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, May 9, 2025. This trademark is owned by Aperio Clinical Outcomes, LLC. The APERIO CLINICAL OUTCOMES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

[Contract research organization (CRO) services, namely, conducting clinical trials for others;] Contract research organization (CRO) services, namely, [ monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies for others, ] clinical trial [project management and ] quality assurance for others, [ medical writing of investigational drug protocols and clinical study reports for others, ] data management and electronic data capture (EDC) database programming of clinical trials [ and biostatistical analysis] for others; Consulting services in the field of conducting clinical trials in the pharmaceutical industry, the biotechnology industry [ and the medical device and diagnostics industries;] Providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy for others; Providing quality assurance services in the medical, pharmaceutical, biotechnology [and medical device...
aperio clinical outcomes

General Information


Serial Number88438039
Word MarkAPERIO CLINICAL OUTCOMES
Filing DateMonday, May 20, 2019
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, May 9, 2025
Registration Number5926109
Registration DateTuesday, December 3, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2019

Trademark Statements


Goods and Services[Contract research organization (CRO) services, namely, conducting clinical trials for others;] Contract research organization (CRO) services, namely, [ monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies for others, ] clinical trial [project management and ] quality assurance for others, [ medical writing of investigational drug protocols and clinical study reports for others, ] data management and electronic data capture (EDC) database programming of clinical trials [ and biostatistical analysis] for others; Consulting services in the field of conducting clinical trials in the pharmaceutical industry, the biotechnology industry [ and the medical device and diagnostics industries;] Providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy for others; Providing quality assurance services in the medical, pharmaceutical, biotechnology [and medical device] fields for others

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 5, 2019
Primary Code042
First Use Anywhere DateThursday, January 18, 2018
First Use In Commerce DateThursday, January 18, 2018

Trademark Owner History


Party NameAperio Clinical Outcomes, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 27701

Party NameAperio Clinical Outcomes, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMorrisville, NC 27560

Party NameAperio Clinical Outcomes, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMorrisville, NC 27560

Trademark Events


Event DateEvent Description
Wednesday, June 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 23, 2019NEW APPLICATION ENTERED
Tuesday, August 6, 2019ASSIGNED TO EXAMINER
Tuesday, August 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2019PUBLISHED FOR OPPOSITION
Tuesday, December 3, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 3, 2019REGISTERED-PRINCIPAL REGISTER
Friday, January 17, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, May 9, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, May 9, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, May 9, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED